Although preliminary, our findings that low FOXP3 mRNA expression in tumor tissue of HPV-negative OSCC was associated with recurrence risk and poor survival were replicated by the independent TCGA cohort, providing additional support for future precise investigation of OSCC immune modulation and its translational implications. This evidence concerns the gene FOXP3 and neoplasm.